tyrosine has been researched along with mercaptopurine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salemnick, G; Stöhrer, G | 1 |
| Mukhtar, H; Murti, CR; Sahib, MK | 1 |
| Hochhaus, A; Lahaye, T; Müller, MC | 1 |
| Coulthard, SA; Hall, AG; Hogarth, LA; Matheson, EC | 1 |
1 review(s) available for tyrosine and mercaptopurine
| Article | Year |
|---|---|
The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
Topics: Alanine; Antimetabolites, Antineoplastic; Azathioprine; DNA; DNA Methylation; Drug Resistance, Neoplasm; Genotype; Humans; Immunosuppressive Agents; Mercaptopurine; Methyltransferases; Models, Biological; Mutation; Phenotype; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine; Time Factors; Tyrosine | 2004 |
3 other study(ies) available for tyrosine and mercaptopurine
| Article | Year |
|---|---|
Oxidizing action of purine N-oxide esters.
Topics: Acetylation; Acetylcysteine; Carbon Radioisotopes; Chemical Phenomena; Chemistry; Chromatography, Paper; Cyclic N-Oxides; Cysteine; Esters; Guanine; Hydrogen-Ion Concentration; Iodides; Iodine; Mercaptopurine; Methionine; Oxidation-Reduction; Purines; Pyridines; Sulfates; Sulfhydryl Compounds; Tryptophan; Tyrosine; Uric Acid; Xanthines | 1975 |
Stabilization of rat liver tyrosine aminotransferase by drugs.
Topics: Animals; Chloroquine; Drug Stability; Enzyme Induction; Liver; Male; Mercaptopurine; Phenacetin; Protein Biosynthesis; Rats; Stimulation, Chemical; Tetracycline; Tyrosine; Tyrosine Transaminase | 1973 |
[Resistance to tumor specific therapy with imatinib by clonal selection of mutated cells].
Topics: Amino Acid Substitution; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Clone Cells; Drug Resistance, Neoplasm; Female; Fusion Proteins, bcr-abl; Histidine; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mercaptopurine; Middle Aged; Oncogene Proteins, Fusion; Piperazines; Point Mutation; Pyrimidines; Selection, Genetic; Tyrosine | 2002 |